Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Pediatrics|December 1, 1995
Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy GroupM B Rennels, S S Wasserman, R I Glass, et al.
The Journal of Infectious Diseases|May 1, 1992
Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversionH C Rimer, S S Wasserman, J Flores, et al.
The American Journal of Physiology|July 1, 1995
Increases in [Ca2+]i mediated by the 92.5-kDa putative cell membrane receptor for HCMV gp86S Keay, B R Baldwin, M W Smith, et al.
Pharmacotherapy|December 29, 2000
Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infectionsK I Plaisance, S Kudaravalli, S S Wasserman, et al.
Infection and Immunity|February 1, 1993
Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protectionG A Losonsky, C O Tacket, S S Wasserman, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1996
Antibodies that react with the capsular polysaccharide of Vibrio vulnificus are detectable in infected patients, and in persons without known exposure to the organismA Fiore, U Hayat, S S Wasserman, et al.
American Journal of Epidemiology|February 25, 1992
A serosurvey of pathogens associated with shellfish: prevalence of antibodies to Vibrio species and Norwalk virus in the Chesapeake Bay regionA Lefkowitz, G S Fout, G Losonsky, et al.
Infection and Immunity|September 1, 1997
Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro modelsJ L Powell, A C Wright, S S Wasserman, et al.
The Journal of Clinical Investigation|August 1, 1992
Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challengeR Harpaz, R Edelman, S S Wasserman, et al.
Vaccine|August 1, 1994
Kinetics of the vibriocidal antibody response to live oral cholera vaccinesS S Wasserman, G A Losonsky, F Noriega, et al.
Pageof 9